O. Schmut

Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy

Weger, M., Stanger, O., Deutschmann, H., Simon, M., Renner, W., Schmut, O., ...

BACKGROUND/AIMS—Hyperhomocyst(e)inaemia has been identified as a strong risk factor for stroke, myocardial infarction, and deep vein thrombosis. A point mutation of methylene tetrahydrofolate...

Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye

Horwath-Winter, J, Bergloeff, J, Floegel, I, Haller-Schober, E-M, Schmut, O

Background: Many patients with essential blepharospasm also show dry eye signs and symptoms. Botulinum toxin A is an effective treatment for reducing spasms in these patients. In this investigation,...

Iodide iontophoresis as a treatment for dry eye syndrome

Horwath-Winter, J, Schmut, O, Haller-Schober, E-M, Gruber, A, Rieger, G

Background/aims: Among the causes related to the development or perpetuation and aggravation of dry eye disease, oxidative reactions may have a role in the pathogenesis of this disorder....